Jeffrey W. Sherman, EVP and Chief Medical Officer: Horizon Therapeutics Public HZNP Sell · Filed 23/01/12

Trade details

Type: Insider sale
Amount: $380,920.8
Shares · price: 3,368 sh · $113.10 a share
Held after: 36,171 sh
Stock: Horizon Therapeutics Public HZNP
Person: Jeffrey W. ShermanEVP and Chief Medical Officer
Trade date: 23/01/11
Filed: 23/01/12
Days to filing: 1 days

Sold 8.5% of holdings

Share of holding sold: 8.5%

Horizon Therapeutics Public trades, last 26 weeks

What else happened in Horizon Therapeutics Public around then

Filed or reported within 30 days of the trade day · 22/12/12~23/02/10

Jeffrey W. Sherman's recent trades

Jeffrey W. ShermanDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$25K
5,000 sh
$25K
Filed 03/02
Traded 02/27
Jeffrey W. ShermanDirector
SellXeris Biopharma Holdings
Sell
Xeris Biopharma Holdings
XERS
$334.5K
42,232 sh
$334.5K
Filed 25/08/29
Traded 25/08/28
Jeffrey W. ShermanDirector
Planned saleXeris Biopharma Holdings
Planned sale
Xeris Biopharma Holdings
XERS
$334.5K
42,232 sh
$334.5K
Filed 25/08/28
Traded 25/08/28
Jeffrey W. ShermanDirector
BuyXeris Biopharma Holdings
Buy
Xeris Biopharma Holdings
XERS
$10.1K
5,400 sh
$10.1K
Filed 23/11/29
Traded 23/11/27
Jeffrey W. ShermanEVP and Chief Medical Officer
SellHorizon Therapeutics Public
Sell
Horizon Therapeutics Public
HZNP
$380.8K
3,368 sh
$380.8K
Filed 23/01/12
Traded 23/01/10

Jeffrey W. Sherman, Chief Officer — sold $380.9K of Horizon Therapeutics Public HZNP · 8.5% of holdings | Whalegun